|Bid||44.53 x 900|
|Ask||44.54 x 800|
|Day's Range||44.15 - 44.84|
|52 Week Range||40.35 - 57.05|
|Beta (5Y Monthly)||0.68|
|PE Ratio (TTM)||17.33|
|Earnings Date||Feb 01, 2023|
|Forward Dividend & Yield||3.76 (8.52%)|
|Ex-Dividend Date||Dec 21, 2022|
|1y Target Est||49.07|
Subscribe to Yahoo Finance Plus to view Fair Value for MO
Clorox's (CLX) Q2 results are likely to reflect gains from strong demand, cost savings, improved productivity and pricing actions. The company's IGNITE strategy also bodes well.
While stocks have generally been under pressure lately, Altria Group (NYSE: MO) has held up better than most. Despite long-term challenges facing the company as more people give up smoking, the tobacco giant's solid near-term outlook and generous dividend suggest that shares could continue to hold up well in the face of volatility for the broader market. Or are there too many risks to the company's business to make it a suitable long-term investment candidate?
Altria Group's (MO) fourth-quarter performance is likely to have witnessed gains from pricing and oral tobacco products amid high costs.